Fractyl Health, Inc. Common Stock
GUTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.04 | 0.16 | -0.16 |
| FCF Yield | -22.10% | -26.81% | -43.90% | -17.19% |
| EV / EBITDA | -1.93 | -4.30 | -3.17 | -3.82 |
| Quality | ||||
| ROIC | -22.55% | -51.92% | -33.36% | -27.03% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.50 | 0.76 | 1.06 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | -70.17% | -39.56% | 128.94% | 452,965.49% |
| Free Cash Flow Growth | -6.69% | 16.57% | -47.84% | 5.40% |
| Safety | ||||
| Net Debt / EBITDA | 0.34 | -1.43 | -0.79 | 0.20 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -1,303.67 | -459.00 | 0.00 |